Indicators

Markets:

News

Latest News about LLY

Recent news which mentions LLY

...

26 27 28 29 30 31 32 33 Next >

This Unstoppable Stock Has Gained 100,203% Over The Last 50 Years, Creating Many Millionaires in the Process. Here Are 3 Reasons I Think It Will Continue to Create Generational Wealth.

September 08, 2024

Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly

September 08, 2024

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?

September 07, 2024

Innovent Bio hopes for plus-sized profits from obesity drug

September 06, 2024

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

September 06, 2024

Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed

September 06, 2024

Comparative Study: Eli Lilly And Industry Competitors In Pharmaceuticals Industry

September 06, 2024

This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem

September 06, 2024

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

September 05, 2024

Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation

September 05, 2024

Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials

September 05, 2024

Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.

September 05, 2024

Why Walgreens Boots Alliance Fell Another 22% in August

September 05, 2024

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race

September 04, 2024

Trade Pulse Power Inflow Alert: Eli Lilly Stock Rises Over 7 Points

September 04, 2024

Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs

September 03, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

September 03, 2024

Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate

September 02, 2024

2 No-Brainer Growth Stocks to Buy With $1,000 Right Now

September 01, 2024

3 No-Brainer Stocks to Buy in September

August 31, 2024

These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now

August 31, 2024

2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000

August 31, 2024

Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits

August 30, 2024

Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients

August 30, 2024

Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your Mind

August 30, 2024

This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock

August 30, 2024

Why Hims & Hers Health Stock Was Falling This Week

August 29, 2024

Decoding Eli Lilly's Options Activity: What's the Big Picture?

August 29, 2024

Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?

August 29, 2024

Here's How Much $1000 Invested In Eli Lilly 10 Years Ago Would Be Worth Today

August 28, 2024

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.